Cambridge Investment Research Advisors
VIAV icon

Cambridge Investment Research Advisors’s Viavi Solutions VIAV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VIAV Stock Details VIAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Sell
118,630
-16,572
-12% -$794K 0.01% 970
2026
Q1 		$4.5M Buy
135,202
+58,622
+77% +$1.55M 0.01% 1025
2025
Q4 		$1.36M Buy
76,580
+62,412
+441% +$1.01M ﹤0.01% 1859
2025
Q3 		$180K Buy
14,168
+2,432
+21% +$26.8K ﹤0.01% 3509
2025
Q2 		$118K Hold
11,736
– – ﹤0.01% 3449
2025
Q1 		$131K Sell
11,736
-331
-3% -$3.68K ﹤0.01% 3310
2024
Q4 		$122K Sell
12,067
-434
-3% -$4.28K ﹤0.01% 3296
2024
Q3 		$113K Sell
12,501
-603
-5% -$4.79K ﹤0.01% 3250
2024
Q2 		$90K Buy
13,104
+95
+0.7% +$739 ﹤0.01% 3166
2024
Q1 		$118K Sell
13,009
-1,867
-13% -$18.3K ﹤0.01% 3134
2023
Q4 		$150K Sell
14,876
-392
-3% -$3.29K ﹤0.01% 2970
2023
Q3 		$140K Buy
15,268
+433
+3% +$4.51K ﹤0.01% 2905
2023
Q2 		$168K Sell
14,835
-2,824
-16% -$27.6K ﹤0.01% 2919
2023
Q1 		$191K Buy
17,659
+1,234
+8% +$13.4K ﹤0.01% 2845
2022
Q4 		$173K Sell
16,425
-2,412
-13% -$29.1K ﹤0.01% 2797
2022
Q3 		$246K Hold
18,837
– – ﹤0.01% 2533
2022
Q2 		$249K Buy
18,837
+3,050
+19% +$43.9K ﹤0.01% 2548
2022
Q1 		$254K Sell
15,787
-4,095
-21% -$67.5K ﹤0.01% 2683
2021
Q4 		$350K Buy
19,882
+1,512
+8% +$24K ﹤0.01% 2391
2021
Q3 		$289K Buy
18,370
+4,132
+29% +$67.8K ﹤0.01% 2499
2021
Q2 		$251K Sell
14,238
-3,862
-21% -$65.2K ﹤0.01% 2608
2021
Q1 		$284K Buy
18,100
+578
+3% +$9.33K ﹤0.01% 2324
2020
Q4 		$262K Buy
17,522
+6,027
+52% +$80.1K ﹤0.01% 2258
2020
Q3 		$135K Sell
11,495
-44
-0.4% -$571 ﹤0.01% 2336
2020
Q2 		$147K Buy
+11,539
New +$138K ﹤0.01% 2249
2014
Q3 		– Sell
-31,319
Closed -$222K – 1500
2014
Q2 		$222K Buy
31,319
+4,550
+17% +$30.9K 0.01% 1153
2014
Q1 		$213K Buy
26,769
+4,386
+20% +$33.1K 0.01% 1128
2013
Q4 		$165K Buy
22,383
+3,244
+17% +$24.6K 0.01% 1121
2013
Q3 		$160K Buy
+19,139
New +$157K 0.01% 1084

Other funds holding VIAV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cambridge Investment Research Advisors's VIAV Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Viavi Solutions (VIAV) stake by 12% in Q2 2026, selling an estimated $794K and leaving 118,630 shares worth $5.67M. The position accounts for 0.01% of the portfolio, ranked #970.

Cambridge Investment Research Advisors first reported a position in VIAV in Q3 2013 and has held it in 29 quarters since. 563 funds tracked by Wall St. Rank hold VIAV as of Q2 2026.

  • Cambridge Investment Research Advisors held 118,630 shares of Viavi Solutions worth $5.67M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 16,572 Viavi Solutions shares in Q2 2026, an estimated $794K.
  • Viavi Solutions made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #970 holding.
  • Cambridge Investment Research Advisors first reported a position in Viavi Solutions in Q3 2013 and has held it in 29 quarters since.
  • 563 funds tracked by Wall St. Rank held Viavi Solutions as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.